Home › Depression › Kansas › Kansas City
Depression clinical trials in Kansas City, KS
3 studies for Depression are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
- The University of Kansas Medical Center, Kansas City
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Recruiting
- University Of Kansas Cancer Center, Kansas City
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
RecruitingPhase 1
- University of Kansas Strawberry Hill Campus, Kansas City
- University of Kansas Medical Center Emergency Department, Kansas City
About Depression
Depression is a serious medical illness. It affects almost 7 percent of U.S. adults. It causes feelings of sadness, hopelessness, and frustration that do not go away. Learn about treatments.
More about Depression on MedlinePlus
Depression trials in other cities
- Boston, MA52 studies
- New York City, NY45 studies
- Philadelphia, PA26 studies
- Atlanta, GA24 studies
- Chicago, IL24 studies
- Pittsburgh, PA22 studies
- San Diego, CA21 studies
- Charleston, SC19 studies
- Houston, TX18 studies
- Orlando, FL17 studies
- Los Angeles, CA17 studies
- Miami, FL16 studies
Other studies in Kansas City
- Cardiovascular Disease14 studies
- Interstitial Lung Diseases13 studies
- Heart Failure13 studies
- Obesity13 studies
- Cystic Fibrosis13 studies
- Bladder Cancer12 studies
- Prostate Cancer12 studies
- Breast Cancer12 studies
- Non-Small Cell Lung Cancer11 studies
- Acute Myeloid Leukemia11 studies
- Lung Cancer11 studies
- COPD9 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.